DCGI recommends allowing Serum Institute to manufacture, stockpile QHPV vaccine - Video
|
Overview
The Drugs Controller General of India has recommended allowing Serum Institute of India to manufacture and stockpile their life-saving qHPV vaccine against cervical cancer, official sources said on Wednesday. The recommendation has been sent to the Union Health Ministry which may issue a gazette notification shortly, they said.
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, had written to the Health Ministry on February 4 seeking approval to manufacture and stockpile the qHPV vaccine as a priority for public health, to save time in making it and to ensure its early availability, an official source said.
For more details, check out the full story on the link below:
Speakers
Rahul Verma joined Medical Dialogues in the year 2022 and is currently working as a Video editor & Medical correspondent. He has completed his graduation in Bachelors of Arts (BA) from IGNOU. He likes to keep himself and the world updated on the occurring in the medical field. He can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
